Unique noncoding variants upstream of PRDM13 are associated with a spectrum of developmental retinal dystrophies including progressive bifocal chorioretinal atrophy.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
05 2019
Historique:
received: 12 11 2018
revised: 23 01 2019
accepted: 24 01 2019
pubmed: 3 2 2019
medline: 10 3 2020
entrez: 3 2 2019
Statut: ppublish

Résumé

The autosomal dominant progressive bifocal chorioretinal atrophy (PBCRA) disease locus has been mapped to chromosome 6q14-16.2 that overlaps the North Carolina macular dystrophy (NCMD) locus MCDR1. NCMD is a nonprogressive developmental macular dystrophy, in which variants upstream of PRDM13 have been implicated. Whole genome sequencing was performed to interrogate structural variants (SVs) and single nucleotide variants (SNVs) in eight individuals, six affected individuals from two families with PBCRA, and two individuals from an additional family with a related developmental macular dystrophy. A SNV (chr6:100,046,804T>C), located 7.8 kb upstream of the PRDM13 gene, was shared by all PBCRA-affected individuals in the disease locus. Haplotype analysis suggested that the variant arose independently in the two families. The two affected individuals from Family 3 were screened for rare variants in the PBCRA and NCMD loci. This revealed a de novo variant in the proband, 21 bp from the first SNV (chr6:100,046,783A>C). This study expands the noncoding variant spectrum upstream of PRDM13 and suggests altered spatio-temporal expression of PRDM13 as a candidate disease mechanism in the phenotypically distinct but related conditions, NCMD and PBCRA.

Identifiants

pubmed: 30710461
doi: 10.1002/humu.23715
doi:

Substances chimiques

5' Untranslated Regions 0
Transcription Factors 0
PRDM13 protein, human EC 2.1.1.-
Histone-Lysine N-Methyltransferase EC 2.1.1.43

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

578-587

Subventions

Organisme : Fight for Sight PhD studentship
ID : 1568/1569
Pays : International
Organisme : Fight for Sight Early Career Investigator Award
ID : 5045/5046
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Raquel S Silva (RS)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.

Gavin Arno (G)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.

Valentina Cipriani (V)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.
Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom.
Department of Genetics, UCL Genetics Institute, Evolution and Environment, London, United Kingdom.

Nikolas Pontikos (N)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.
Department of Genetics, UCL Genetics Institute, Evolution and Environment, London, United Kingdom.

Sabine Defoort-Dhellemmes (S)

Exploration de la Vision et Neuro-Ophtalmologie, Centre Hospitalier Universitaire, Lille, France.

Ambreen Kalhoro (A)

Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.

Keren J Carss (KJ)

Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
NIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom.

F Lucy Raymond (FL)

NIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.

Claire Marie Dhaenens (CM)

Biochemistry and Molecular Biology Department-UF Génopathies, CHU Lille, Univ Lille, Inserm UMR-S 1172, F-59000, Lille, France.

Hanne Jensen (H)

Department of Ophthalmology, The Kennedy Eye Clinic, Rigshospitalet Glostrup, Glostrup, Denmark.

Thomas Rosenberg (T)

Department of Ophthalmology, The Kennedy Eye Clinic, Rigshospitalet Glostrup, Glostrup, Denmark.

Veronica van Heyningen (V)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.

Anthony T Moore (AT)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.
Department of Ophthalmology, UCSF School of Medicine, San Francisco, CA.

Bernard Puech (B)

Exploration de la Vision et Neuro-Ophtalmologie, Centre Hospitalier Universitaire, Lille, France.

Andrew R Webster (AR)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Genetics, Moorfields Eye Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH